Technical Analysis for ATNF - 180 Life Sciences Corp.

Grade Last Price % Change Price Change
F 3.40 -3.82% -0.14
ATNF closed down 5.36 percent on Friday, February 3, 2023, on 6 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction -3.82%
Inside Day Range Contraction -3.82%
Wide Bands Range Expansion -3.82%
Oversold Stochastic Weakness -3.82%
20 DMA Resistance Bearish -8.98%
Pocket Pivot Bullish Swing Setup -8.98%
Wide Bands Range Expansion -8.98%
Oversold Stochastic Weakness -8.98%
Stochastic Buy Signal Bullish 3.82%
Narrow Range Bar Range Contraction 3.82%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 5% about 4 hours ago
60 Minute Opening Range Breakdown about 4 hours ago
Down 3% about 7 hours ago
Down 2 % about 7 hours ago
Up 1% about 7 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

180 Life Sciences Corp. is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease – inflammation. The Company is driving groundbreaking study into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The Company’s primary platform is a novel program to treat fibrosis using anti-TNF, with its lead program in phase 2b/3 clinical trials.
Classification

Sector: Industrials
Industry: Conglomerates
Keywords: Biotechnology Clinical Medicine Disease Immunology Pain Inflammation Inflammatory Diseases Cytokine Fibrosis Tumor Necrosis Factor Human Physiology Animal Physiology

Is ATNF a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 71.4
52 Week Low 1.18
Average Volume 5,347,536
200-Day Moving Average 15.86
50-Day Moving Average 4.70
20-Day Moving Average 3.73
10-Day Moving Average 3.48
Average True Range 0.89
RSI 48.72
ADX 38.8
+DI 34.99
-DI 13.10
Chandelier Exit (Long, 3 ATRs) 4.49
Chandelier Exit (Short, 3 ATRs) 5.75
Upper Bollinger Bands 4.84
Lower Bollinger Band 2.63
Percent B (%b) 0.41
BandWidth 59.33
MACD Line -0.31
MACD Signal Line -0.40
MACD Histogram 0.0876
Fundamentals Value
Market Cap 63.65 Million
Num Shares 18 Million
EPS
Price-to-Sales 0.00
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.05
Resistance 3 (R3) 4.05 3.88 3.97
Resistance 2 (R2) 3.88 3.74 3.88 3.94
Resistance 1 (R1) 3.70 3.66 3.61 3.70 3.91
Pivot Point 3.53 3.53 3.48 3.53 3.53
Support 1 (S1) 3.35 3.39 3.27 3.36 3.15
Support 2 (S2) 3.18 3.31 3.18 3.12
Support 3 (S3) 3.00 3.18 3.09
Support 4 (S4) 3.01